Association between Oncologic Drugs Advisory Committee (ODAC) members’ financial conflicts of interest (FCOIs) and recommendations for drug approval by the U.S. Food and Drug Administration (FDA)

Autor:	Alberto Ocaña, Agustí Barnadas, Bostjan Seruga, Arnoud J. Templeton, Ariadna Tibau Martorell, Eitan Amir
Rok vydání:	2015
Předmět:	Food and drug administration Cancer Research medicine.medical_specialty Oncology business.industry Family medicine Advisory committee medicine Drug approval business humanities health care economics and organizations
Zdroj:	Journal of Clinical Oncology. 33:6582-6582
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2015.33.15_suppl.6582
Popis:	6582 Background: FDA advisory committees influence decisions relating to the regulatory approval of drugs in the United States. Little is known about whether ODAC members’ FCOIs affect the FDA’s on...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::19b53bc20380bab608bb85af5f13e85a https://doi.org/10.1200/jco.2015.33.15_suppl.6582 Zobrazit plný text záznamu